Through close collaboration with customers developing innovative therapies for a variety of life-improving indications, Sinclair Research has developed strong therapeutic expertise in a number of therapeutic areas including dermal, metabolic diseases and inflammation. Our team of talented veterinary surgeons and experienced pharmacology and toxicology scientists combine expertise in a variety of modalities, molecules and disease indications to support in vivo studies that progress the development of your novel drug candidate.
Why partner with Sinclair Research?
As one of the largest nonclinical CROs in North America, Sinclair Research’s scientific and technical expertise can provide you with the therapeutic expertise you need, the data you expect, and the customer experience you deserve! Contact our team to discuss your upcoming research and meet with our scientific experts to discuss how to reach your next development milestone.
Our Therapeutic Service Areas include
Sinclair Research can model pathophysiological and metabolic changes in laboratory animals by chemical induction, genetic intervention, or dietary modification.
We are experts in diabetes induction, diabetes maintenance, and conduction of drug or therapeutic (PK/PD) studies in the diabetic miniature swine.
Sinclair Research has expanding pharmacology and inflammatory diseases programs, including models of inflammatory joints and osteoarthritis in multiple species.
Sinclair Research is a center of excellence in dermal toxicity testing, conducting GLP-compliant dermal and transdermal toxicology and safety studies.
Sinclair has performed dermal wound healing studies in miniature swine models and other species. Resident experts provide guidance to our wound healing program.
Osteoarthritis, cartilage and bone healing/repair are among the orthopedic studies offered at Sinclair, as well as implantable devices in a variety of bone classes.
and resources for pre-clinical in-vivo evaluation of ocular therapeutics.